<p>Average dissolution profile of the tablets with minimum and maximum variations.</p
The dissolution test consists of two parts;the prepa-ration of the sample which is performed with th...
<p>Summary of average properties of the overall screening set and specific compounds.</p
The subdivision of sustained release tablets is a controversial issue, especially concerning its imp...
Dissolution of the active pharmaceutical ingredient determined for each sample.</p
<p>Dissolution profile (mean ± SD, n = 6) of Bendex and Ovis in 0.1 N HCl (900 ml) using USP II appa...
<p>Percentual component concentration of the formulations proposed for the tablet.</p
<p>Variation coefficients regarding the robustness evaluation of the dissolution test.</p
A novel bending point criterion was developed and compared with a number of existing criteria for th...
A drug dissolution profile is one of the most critical dosage form characteristics with immediate an...
Dissolution profiles for TP (1), TP-β-CD physical mixture (2) and TP-β-CD inclusion complex (3) in p...
The use of non-linear mixed effects models to describe dissolution data has been evaluated, A theore...
<p>The vertical bars represent the 95% confidence interval limits for the measured content variation...
Average monthly pharmaceutical prescriptions per patient before, during and after the reform announc...
<span>In recent years, drug release/</span><span class="highlight">dissolution</span><span> from sol...
Dissolution profiles for TP (1), TP-β-CD physical mixture (2) and TP-β-CD inclusion complex (3) in a...
The dissolution test consists of two parts;the prepa-ration of the sample which is performed with th...
<p>Summary of average properties of the overall screening set and specific compounds.</p
The subdivision of sustained release tablets is a controversial issue, especially concerning its imp...
Dissolution of the active pharmaceutical ingredient determined for each sample.</p
<p>Dissolution profile (mean ± SD, n = 6) of Bendex and Ovis in 0.1 N HCl (900 ml) using USP II appa...
<p>Percentual component concentration of the formulations proposed for the tablet.</p
<p>Variation coefficients regarding the robustness evaluation of the dissolution test.</p
A novel bending point criterion was developed and compared with a number of existing criteria for th...
A drug dissolution profile is one of the most critical dosage form characteristics with immediate an...
Dissolution profiles for TP (1), TP-β-CD physical mixture (2) and TP-β-CD inclusion complex (3) in p...
The use of non-linear mixed effects models to describe dissolution data has been evaluated, A theore...
<p>The vertical bars represent the 95% confidence interval limits for the measured content variation...
Average monthly pharmaceutical prescriptions per patient before, during and after the reform announc...
<span>In recent years, drug release/</span><span class="highlight">dissolution</span><span> from sol...
Dissolution profiles for TP (1), TP-β-CD physical mixture (2) and TP-β-CD inclusion complex (3) in a...
The dissolution test consists of two parts;the prepa-ration of the sample which is performed with th...
<p>Summary of average properties of the overall screening set and specific compounds.</p
The subdivision of sustained release tablets is a controversial issue, especially concerning its imp...
DOI
Add to ORKG